ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
BPC-157/TB-500 Dosing
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="BigTex" data-source="post: 260142" data-attributes="member: 43589"><p>I am strictly going by this study which seems to be the only one available. While the sample size is small and it was more of an observational study. Seems the combination of the two or BPC 157 is very effective. y the way, TB4 is the natural form found in humans. TB 500 is the synthetic version of TB4.</p><p></p><p style="margin-left: 20px"><strong><em>Results •</em></strong><em> Of the 16 patients, 12 had received only BPC 157 as an intra-articular injection. In this group, 11 of the 12 patients (91.6%) had significant improvement in knee pain, whereas 1 patient (8.3 %) had no improvement. The other 4 patients received a combination of 2 peptide injections of BPC 157 and TB4. Of the patients who received both peptides, 75% showed significant improvement, but 25% had no relief of their knee pain. Overall, 14 of 16 patients (87.5%) had relief of their knee pain when BPC 157 or a combination of BPC 157 and TB4 was used.</em></p> <p style="margin-left: 20px"></p> <p style="margin-left: 20px"><em>The dose of BPC 157 was 2 cc or 4 mg (2000 mcg/ml). The dose of BPC 157 with TB4 varied from a low dose of BPC157 of 2 mg (1 cc) and 3 mg (1 cc) of TB4 to a high dose of BPC 157 of 4 mg (2cc) combined with 6 mg (2cc) of TB4.</em></p><p></p><p>I am using both BPC 157 and TB 500 (2mg TB 500/1mg BPC 157). Plus I added 4iu of hGH. After 4 weeks of treatment I am definitely seeing some improvement in the pain level in the osteoarthritis in the shoulders and knee.</p><p></p><p>(2.0 TB-500 2 x WK for approximately 4-6 weeks. After 1-2 times month. I am also using 1000mg of BPC 157 every day and 4iu hGH 1 x WK in the shoulder and knee.)</p><p style="margin-left: 20px"></p> <p style="margin-left: 20px"><em>25 G 1.5-inch needle was inserted into the knee via the medial tibia plateau area and 2 cc of BPC 157 was injected into the knee joint. Injections of BPC 157 with TB4<strong> ranged from 1 cc of BPC157 plus 1 cc of TB4 to 2 cc of BPC 157 plus 2 cc of TB4.</strong></em></p> <p style="margin-left: 20px"></p> <p style="margin-left: 20px"><em><strong>Procedure</strong></em></p> <p style="margin-left: 20px"><em>The peptides were created via solid phase peptide synthesis and compounded by Tailor Made Compounding in Nicholasville, Kentucky. BPC157 was compounded at 2000 mcg/ml concentration and TB4 at 3000 mcg/ml concentration. Both were buffered with sodium phosphate buffer and benzyl alcohol for sterility and stability.</em></p><p></p><p>[ATTACH=full]34864[/ATTACH]</p><p>[ATTACH=full]34865[/ATTACH]</p></blockquote><p></p>
[QUOTE="BigTex, post: 260142, member: 43589"] I am strictly going by this study which seems to be the only one available. While the sample size is small and it was more of an observational study. Seems the combination of the two or BPC 157 is very effective. y the way, TB4 is the natural form found in humans. TB 500 is the synthetic version of TB4. [INDENT][B][I]Results •[/I][/B][I] Of the 16 patients, 12 had received only BPC 157 as an intra-articular injection. In this group, 11 of the 12 patients (91.6%) had significant improvement in knee pain, whereas 1 patient (8.3 %) had no improvement. The other 4 patients received a combination of 2 peptide injections of BPC 157 and TB4. Of the patients who received both peptides, 75% showed significant improvement, but 25% had no relief of their knee pain. Overall, 14 of 16 patients (87.5%) had relief of their knee pain when BPC 157 or a combination of BPC 157 and TB4 was used.[/I][/INDENT] [INDENT][/INDENT] [INDENT][I]The dose of BPC 157 was 2 cc or 4 mg (2000 mcg/ml). The dose of BPC 157 with TB4 varied from a low dose of BPC157 of 2 mg (1 cc) and 3 mg (1 cc) of TB4 to a high dose of BPC 157 of 4 mg (2cc) combined with 6 mg (2cc) of TB4.[/I][/INDENT] I am using both BPC 157 and TB 500 (2mg TB 500/1mg BPC 157). Plus I added 4iu of hGH. After 4 weeks of treatment I am definitely seeing some improvement in the pain level in the osteoarthritis in the shoulders and knee. (2.0 TB-500 2 x WK for approximately 4-6 weeks. After 1-2 times month. I am also using 1000mg of BPC 157 every day and 4iu hGH 1 x WK in the shoulder and knee.) [INDENT][/INDENT] [INDENT][I]25 G 1.5-inch needle was inserted into the knee via the medial tibia plateau area and 2 cc of BPC 157 was injected into the knee joint. Injections of BPC 157 with TB4[B] ranged from 1 cc of BPC157 plus 1 cc of TB4 to 2 cc of BPC 157 plus 2 cc of TB4.[/B][/I][/INDENT] [INDENT][/INDENT] [INDENT][I][B]Procedure[/B][/I][/INDENT] [INDENT][I]The peptides were created via solid phase peptide synthesis and compounded by Tailor Made Compounding in Nicholasville, Kentucky. BPC157 was compounded at 2000 mcg/ml concentration and TB4 at 3000 mcg/ml concentration. Both were buffered with sodium phosphate buffer and benzyl alcohol for sterility and stability.[/I][/INDENT] [ATTACH type="full" alt="BPC.JPG"]34864[/ATTACH] [ATTACH type="full" alt="TB500.JPG"]34865[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
BPC-157/TB-500 Dosing
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top